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RESEARCH ARTICLE Open Access
Borrelia burgdorferi induces a type I
interferon response during early stages of
disseminated infection in mice
Mary M. Petzke1*, Radha Iyer1, Andrea C. Love1,3, Zoe Spieler1, Andrew Brooks2 and Ira Schwartz1
Abstract
Background: Lyme borrelia genotypes differ in their capacity to cause disseminated disease. Gene array analysis
was employed to profile the host transcriptome induced by Borrelia burgdorferi strains with different capacities for
causing disseminated disease in the blood of C3H/HeJ mice during early infection.
Results: B. burgdorferi B515, a clinical isolate that causes disseminated infection in mice, differentially regulated 236
transcripts (P < 0.05 by ANOVA, with fold change of at least 2). The 216 significantly induced transcripts included
interferon (IFN)-responsive genes and genes involved in immunity and inflammation. In contrast, B. burgdorferi B331,
a clinical isolate that causes transient skin infection but does not disseminate in C3H/HeJ mice, stimulated changes
in only a few genes (1 induced, 4 repressed). Transcriptional regulation of type I IFN and IFN-related genes was
measured by quantitative RT-PCR in mouse skin biopsies collected from the site of infection 24 h after inoculation
with B. burgdorferi. The mean values for transcripts of Ifnb, Cxcl10, Gbp1, Ifit1, Ifit3, Irf7, Mx1, and Stat2 were found to
be significantly increased in B. burgdorferi strain B515-infected mice relative to the control group. In contrast,
transcription of these genes was not significantly changed in response to B. burgdorferi strain B331 or B31-4, a
mutant that is unable to disseminate.
Conclusions: These results establish a positive association between the disseminating capacity of B. burgdorferi and
early type I IFN induction in a murine model of Lyme disease.
Keywords: Lyme disease, Type I interferon, Bacterial pathogenesis, Mouse model
Background
Lyme disease, the most common vector-borne infection
in North America [1], is caused by the spirochete
Borrelia burgdorferi and transmitted through the feeding
of infected Ixodes species ticks [2]. Approximately
70–80 % of patients develop a characteristic skin lesion,
erythema migrans (EM), at the site of inoculation that is
characterized by an influx of immune cells, predominantly
T lymphocytes, macrophages/monocytes, and dendritic
cells [3, 4]. If left untreated with recommended antibiotic
therapy [5], sequelae of Lyme disease can include rheuma-
tologic, neurologic and cardiac symptoms following
hematogenous dissemination of the spirochete from the
site of inoculation in the skin to target tissues such as the
joints, central nervous system and heart [6].
The potential for dissemination is likely dependent on
multiple host and pathogen factors, including the exist-
ence of diverse B. burgdorferi genotypes that can be clas-
sified based on a number of molecular characteristics,
including restriction fragment-length polymorphism of
the 16S-23S ribosomal DNA spacer region (ribosomal
spacer type; RST) and the sequence of outer surface pro-
tein C (OspC) [7]. Numerous studies have established an
association between genotype and the capacity to cause
invasive disease. RST1 strains are more likely to cause
disseminated infection in Lyme disease patients, whereas
RST2 and RST3 strains are less frequently detected in
the blood [8–11]. Four of the 16 identified OspC geno-
types were found to account for 80 % of cases of dissem-
inated Lyme disease in the Northeastern United States,
including both of the OspC genotypes corresponding to
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RST1 (OspC A and B); in contrast, only one of the four
OspC genotypes associated with RST2 (OspC K), and
one of the ten OspC genotypes associated with RST3
(OspC I), were identified as highly invasive [11]. These
correlative data were confirmed by direct experimental
validation using a murine model of Lyme borreliosis; in-
fection of C3H/HeJ mice with RST1 strains resulted in
significantly higher spirochete loads in tissue, and more
severe arthritis and carditis, than did infection with
RST3 isolates, some of which did not disseminate from
the inoculation site [12, 13].
B. burgdorferi elicits the production of both pro- and
anti-inflammatory cytokines via recognition of spiro-
chetal cellular components by cells of the host’s innate
immune system [14–17]. The induced cytokine profile
may have a critical impact on disease outcome, as a
strong pro-inflammatory response early in infection
appears to mediate host protection in both mice and in
Lyme disease patients [4, 18–21]. Intriguingly, expres-
sion profiling of a murine macrophage cell line
stimulated with diverse B. burgdorferi clinical isolates
revealed no genotype-specific differences in mRNA or
protein levels for a number of pro-inflammatory cyto-
kines known to be associated with Lyme disease patho-
genesis [22]. Similar results were observed when
comparing B. burgdorferi clinical isolates of varying
genotype using an ex vivo human peripheral blood
mononuclear cell (PBMC) model and measuring
secreted cytokine proteins [23]. However, the latter
study identified a correlation between the induction of
IFN-α, a type I interferon (IFN), and B. burgdorferi
genotype; significantly higher levels of IFN-α were elic-
ited by strains with a greater capacity for dissemination
[23]. This finding was corroborated by a separate study
in which RST1 isolates induced significantly greater
IFN-α production by human PBMCs relative to RST3
isolates [24]. Type I IFNs have also been detected in
serum and in blister fluids raised over EM lesions of
Lyme disease patients and serum levels of IFN-α were
found to be significantly higher in patients with mul-
tiple EM skin lesions, an indication of disseminated
Lyme disease, relative to patients with a single EM lesion
[4]. In addition, type I IFNs and IFN-responsive genes are
expressed in the joints of B. burgdorferi-infected mice and
play a crucial role in the subsequent development of Lyme
arthritis [25, 26].
The present study was designed to identify host tran-
scriptional alterations, including those of IFN-responsive
genes, elicited in a murine model of Lyme borreliosis.
Gene array analysis was employed to profile global gene
expression changes induced by B. burgdorferi strains of
varying genotypes in mouse whole blood at 14 days
post-inoculation. Additionally, transcription of type I IFNs
and IFN-related genes was measured 24 h post-infection
in mouse skin at the site of intradermal inoculation with
various B. burgdorferi strains.
Results
Differential infection outcomes in mice inoculated with
B. burgdorferi clinical isolates
C3H/HeJ mice were inoculated with B. burgdorferi B515,
an RST1 strain that causes disseminated infection in
mice [13] or B. burgdorferi B331, an RST3A strain that
is unable to disseminate from the skin [13]. Forty-four
(97.8 %) of the 45 blood and tissue samples collected on
day 28 from mice infected with B. burgdorferi B515
were positive by culture (Table 1). In contrast, spiro-
chetes could not be recovered from any tissues collected
from mice infected with B. burgdorferi B331 (0/60; 0 %).
Notably, culture positivity from all individual tissues
assessed was significantly higher for mice infected with
B. burgdorferi B515 as compared with B. burgdorferi
B331 (P < 0.001) (Table 1). To confirm disseminated
infection in B515-infected mice, development of joint
swelling as an indicator of clinically apparent arthritis was
monitored by measurement of the ankle-joint diameter
using a digital caliper on days 7, 14, 21 and 28 post-
infection. The average ankle joint diameters were signifi-
cantly greater for mice infected with B. burgdorferi B515
as compared to mice infected with B. burgdorferi B331 or
medium-inoculated controls at each of these time points
(P < 0.0001) (Fig. 1). Taken together, these results confirm
the development of disseminated infection in mice inocu-
lated with B. burgdorferi B515, but not in B. burgdorferi
B331-inoculated animals.
B. burgdorferi elicits genotype-dependent transcriptional
profiles in mouse blood
Gene array analysis was performed in order to exam-
ine the host global transcriptome changes elicited by
B. burgdorferi in blood. RNA was isolated from whole
blood collected on day 14, when disseminated infec-
tion could be confirmed by culture of ear biopsies. A
total of 239 transcripts was defined as differentially
regulated based on having a P value of <0.05 and fold-
change of at least 2 relative to the control group. The
Table 1 Culture of B. burgdorferi from tissue specimens of
infected mice
Number of samples with positive cultures/number tested (%)
Day 14 Day 28
Ear Ear Skin a Bladder Jointb
B515c 15/15 (100) 12/12 (100)d 13/14 (92.9) 14/14 (100) 5/5 (100)
B331 0/15 (0.0) 0/15 (0) 0/15 (0.0) 0/15 (0) 0/5 (0)
aSkin biopsy was collected from the inoculation site
bJoints were cultivated from one mouse per subgroup
cOne mouse in the B515-infected group died between Day 14 and Day 28
dTwo samples were contaminated
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response to B. burgdorferi B515 included 236 differentially
regulated transcripts (216 induced, 20 repressed). In con-
trast, B. burgdorferi B331 stimulated changes in relatively
few transcripts (1 induced, 4 repressed); this result was
not unexpected, as spirochetes could not be recovered
from the tissues of any of the B. burgdorferi B331-infected
mice (Table 1). The 239 differentially regulated transcripts
were subjected to hierarchical clustering based on
both transcript (probe set) and experimental condition
(Fig. 2). Samples from mice that had been infected
with B. burgdorferi B515 displayed similar transcrip-
tional profiles and clustered together. In contrast, samples
from B. burgdorferi B331-infected mice formed a second
cluster together with samples from medium-inoculated
control animals.
To validate the expression values generated by gene
array, transcript levels for five genes were assessed by
real-time RT-PCR (Table 2). Although the absolute
values obtained by gene array and RT-PCR varied, a
similar trend in transcriptional expression was observed
by both methods for all of the genes assayed. In sum-
mary, these findings demonstrate that transcriptional
changes in mouse blood vary according to the infecting
Borrelia strain.
B. burgdorferi induces expression of inflammatory and
anti-microbial transcripts during disseminated infection
including IFN-responsive genes
Selected induced and repressed transcripts involved in
the immune response are presented (Tables 3 and 4).
B. burgdorferi B515 elicited elevated expression of
genes with defined roles in antimicrobial defense, re-
modeling of the extracellular matrix, dermal inflam-
matory conditions, innate immunity, B cell activation
and the development of humoral immunity (Ighg) and
the generation of tolerogenic dendritic cells (Clec4a2)
[27]. Among the most highly induced transcripts were
lactotransferrin (Ltf ); cathelicidin antimicrobial pep-
tide (Camp) and its receptor, formyl peptide receptor



































Fig. 1 Arthritis development in infected mice. Groups of 15 C3H/HeJ mice were inoculated intradermally by needle with 1×104 spirochetes of
B. burgdorferi strains B515 or B331, or with medium (control). Tibiotarsal joints were measured on days 0, 7, 14, 21, and 28 post-infection. Measurements
are shown as the mean value of each experimental group, with bars indicating the standard deviation. ****, P < 0.0001 relative to the control and
B331-infected groups
Table 2 Real-time RT-PCR validation of gene array results
B515 B331
Probe set ID Gene symbol Gene name Arraya RT-PCRa Array RT-PCR
1419691_at Camp cathelicidin antimicrobial peptide 4.0 6.5 −1.1 −1.2
1418722_at Ngp neutrophilic granule protein 5.6 25.6 −1.2 1.8
1420549_at Gbp1 guanylate binding protein 1 1.9 −1.1 1.1 −1.7
1427256_at Vcan (Cspg2) versican 4.1 12.2 1.2 1.9
1423466_at Ccr7 chemokine (C-C motif) receptor 7 −1.9 −1.2 −1.2 1.0
aMean fold change values relative to medium-inoculated control group
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and lipocalin 2 (Lcn2). Also included was the gene
encoding TLR13, which has recently been identified
as a receptor for bacterial ribosomal RNA [28–30], as
well as genes encoding two proteins (TLR2 and CD14)
with established roles in the innate immune response
to B. burgdorferi lipoproteins [31–33]. Two of the in-
duced transcripts (Ifitm2 and Ifitm6) contained the
term “interferon induced” in the gene title. A database
search for interferon-responsive genes identified 92 of
the 216 (42.6 %) B515-induced transcripts as interferon
responsive (http:www.interferome.org).
Twenty transcripts were repressed by B. burgdorferi
B515 (Table 4). Of these, two transcripts (Pfn2, profilin
and Tnfrsf13c, tumor necrosis factor receptor superfam-
ily, member 13c) were also repressed by B. burgdorferi
B331. Pfn2 has an annotated function in cytoskeleton
organization and Tnfrsf13c is involved in B-cell homeo-
stasis. Other transcripts involved in humoral immunity
were repressed by B515; these included Fcer2a (Fc re-
ceptor, IgE, low affinity II, alpha polypeptide), Ighv14-2
(immunoglobulin heavy variable 14–2), and Ebf1 (early B
cell factor).
Induction of type I IFN and IFN-responsive genes by
B. burgdorferi in skin correlates with capacity for
dissemination
Expression of IFN-responsive genes has been shown to
be a critical factor in the development of arthritis in a
susceptible mouse model of Lyme borreliosis [25, 26].
The observation that a type I IFN response can be de-
tected in the blood at day 14 post-inoculation, however,
suggested a potential role for type I IFNs during earlier
stages of infection. In order to evaluate the differential
expression of type I IFN-related genes at the site of in-
oculation in mouse skin, groups of nine mice were inoc-
ulated with 1×104 spirochetes of B. burgdorferi strains
B515, B331, or B31–4, a derivative of type strain B31
(RST1) that lacks all linear plasmids, is unable to dis-
seminate in mice [34] and does not induce a type I IFN
response by human peripheral blood mononuclear cells
[23]. Skin biopsies were collected 24 h post-inoculation
for RNA isolation and tissues samples were collected at
day 14 or day 28 for assessment of culture positivity.
Spirochetes could be recovered from 24-h skin biopsies
collected from the site of inoculation from all four
(100 %) of the B. burgdorferi B515-infected mice and from
at least one additional tissue from each of these mice.
Interestingly, although 24-h skin biopsies from 75 % (3/4)
of B331-infected mice were culture positive, spirochetes
could not be recovered from any of the tissues from these
mice. As expected, neither the 24-h skin biopsies nor the
14 or 28 day tissues collected from B31-4-inoculated mice
were culture positive (Table 5). This indicates that inocu-
lation with strain B331 resulted in transient infection at
the injection site, but these spirochetes could not establish
infection at distal tissue sites.
RNA was isolated from skin biopsies of five mice that
were either mock-infected or inoculated with B. burgdor-
feri strain B515. These RNAs were separately pooled and
used as templates for RT-PCR using the RT2 Profiler
PCR Array PAMM-016: Mouse Interferon α,β Response
kit (SABiosciences). This kit profiles the expression of
84 genes involved in the IFN-α and IFN-β immune re-
sponse, including signaling molecules, IFN-responsive
genes, and genes associated with interferon resistance.
Fifteen genes were induced >2-fold in B. burgdorferi
B515-infected mouse skin relative to the medium-
inoculated control group (Fig. 3). These genes included
Ifit3 (15.7-fold), Ifit1 (4.3-fold), Cxcl10 (3.4-fold), Irf7
(3.3-fold), Gbp1 (2.6-fold), and Stat2 (2.3-fold).
Based on these PCR array results, differential induc-
tion of type I IFNs and selected IFN-responsive genes by
B. burgdorferi was further evaluated by real-time RT-
PCR analysis of RNA isolated from 24-h skin biopsies
collected from individual animals. RNA was obtained
from all nine of the mice in each of the B. burgdorferi
B515-infected and control groups, and from seven
Fig. 2 Hierarchical clustering of differentially regulated probe sets in
Borrelia-infected mouse blood. A total of 239 probe transcripts were
defined as differentially regulated (P< 0.05 and fold change of at least 2
relative to the medium-inoculated controls) in mouse blood at day 14
post-inoculation with B. burgdorferi strains B515 or B331. Differentially
regulated probe sets were subjected to unsupervised hierarchical
clustering based on transcript and experimental condition. Results
are displayed as heat maps of the log of the normalized intensity
values for individual samples (left) or averaged values for each
experimental group (right)
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animals each in the groups that had been infected
with B. burgdorferi strains B31-4 and B331. Transcript
levels were assessed for genes encoding murine IFN-β
(Ifnb) and the IFN-responsive genes Cxcl10, Mx1,
Irf3, Irf7, Gbp1, Stat2, Ifit1, and Ifit3. With the excep-
tion of Irf3, the mean fold-change values for all genes
assessed were found to be significantly elevated in the
skin of B. burgdorferi B515-infected mice relative to
the medium-inoculated control group: Mx1 (9.5-fold),
Ifnb (4.4-fold), Cxcl10 (8.0-fold), Irf7 (8.1-fold), Gbp1
(16.0-fold), Stat2 (6.8-fold), Ifit1 (18.8-fold), and Ifit3
(16.2-fold) (Fig. 4). In contrast, none of the genes
assessed was found to be significantly induced or re-
pressed relative to the controls in the mice inoculated
with either B. burgdorferi strains B31-4 or B331. All
genes except Ifit3 were significantly induced in B. burg-
dorferi B515-infected mice relative to B. burgdorferi
B31-4-inoculated mice (P < 0.01). In addition, transcript
levels for Cxcl10, Irf3, Irf7, Gbp1, Stat2, and Ifit1
were also significantly higher in skin at the inocula-
tion site of mice infected with B. burgdorferi strain
B515 as compared to animals infected with B. burg-
dorferi strain B331 (P < 0.05). These results demon-
strate that only the B. burgdorferi strain capable of
causing disseminated infection induces significant ex-
pression of type I IFN-related genes in mouse skin
during early infection, in contrast to strains that do
not disseminate.
Table 3 Transcripts significantly induced in mouse blood in response to B. burgdorferi




Transcripts induced by B. burgdorferi B515
Mm. 387173 Chi3l3 chitinase 3-like 3 Inflammatory response 9.14 1.17
Mm.9537 Lcn2 lipocalin 2 Response to virus 7.25 −1.43
Mm.236225 Ngp neutrophil granule protein Defense response to bacterium 5.64 −1.20
Mm.16415 Mmp8 matrix metallopeptidase 8 Proteolysis 5.21 1.01
Mm.1349 Il1r2 Interleukin 1 receptor, type II Lipid metabolic process 4.78 −1.02
Ighg Immunoglobulin heavy chain (gamma polypeptide) 4.23 −1.08
Mm.158700 Vcan versican Cell adhesion, heart development 4.10 1.20
Mm.248327 Clec4e C-type lectin domain family 4, member e Immune response 4.03 1.11
Mm.3834 Camp cathelicidin antimicrobial protein Defense response to bacterium 3.96 −1.09
Mm.274927 Ccr1 chemokine (C-C) receptor 1 Inflammatory response 3.68 −0.05
Mm.24208 Il13ra1 interleukin 13 receptor, alpha 1 Cytokine-mediated signaling pathway 3.63 1.15
Mm.477887 Fpr2 formyl peptide receptor 2 G-protein coupled receptor signaling 3.62 −1.35
Mm.282359 Ltf lactotransferrin Iron ion transport, homeostasis 3.60 −1.15
Mm.248360 Anxa1 annexin A1 Leukocyte homeostasis 3.45 −1.26
Mm.9277 Pla2g7 phospholipase A2, group VII Inflammatory response 3.41 1.14
Mm.882 Il1rn interleukin 1 receptor antagonist Negative regulation of cytokine-mediated signaling 3.30 1.25
Mm.87596 Tlr2 toll-like receptor 2 Pattern recognition receptor signaling pathway 3.01 −1.12
Mm.276440 Ifitm6 interferon induced transmembrane protein 6 Response to biotic stimulus 3.00 −1.30
Mm.143718 Mefv Mediterranean fever Inflammatory response 2.93 1.09
Mm.19131 C3 complement component 3 Inflammatory response, innate 2.91 −1.04
Mm.486 Lamp2 lysosomal-associated membrane protein 2 2.89 −1.09
Mm.336203 Tlr13 toll-like receptor 13 Inflammatory response, signal Transduction 2.72 −1.22
Mm.3460 Cd14 CD14 antigen Response to molecule of bacterial origin 2.60 −1.44
Mm.170515 Nfkbia nuclear factor of kappa light polypeptide gene
enhancer in B cells inhibitor, alpha
Protein import into nucleus, Translocation 2.55 −1.29
Mm.47384 Clec4a2 C-type lectin domain family 4, member a2 Immune response 2.48 1.10
Mm.379266 Ifitm2 interferon induced transmembrane protein 2 Response to biotic stimulus 2.41 −1.22
Transcript induced by B. burgdorferi B331
Mm247642 Arap3 ArfGAP with RhoGAP domain, ankyrin repeat
and PH domain
Signal transduction 1.71 2.02
aFC = fold change
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Discussion
In this study we utilized host transcriptional profiling to
identify alterations in gene expression that occur following
intradermal inoculation of B. burgdorferi in a murine infec-
tion model. For a strain of B. burgdorferi that causes dis-
seminated infection, a number of IFN-inducible genes were
expressed both during acute localized infection at the in-
oculation site in skin and in blood collected 14 days after
infection. This finding is consistent with numerous studies
demonstrating an association between the induction of
IFNs and Lyme disease pathogenesis. In human patients,
significantly higher expression of serum IFN-α protein is
associated with disseminated infection, as defined by the
presence of multiple EM skin lesions as compared to patients
with a single EM [4]. Transcripts for IFN-β are induced in
human monocytes and PBMCs during co-culture with B.
burgdorferi [35, 36]. Recently, we demonstrated that B. burg-
dorferi clinical isolates which are more frequently associated
with disseminated infection in mice and humans induce sig-
nificantly higher levels of IFN-α protein in human PBMCs as
compared with isolates that are less likely to disseminate
[23]. The current results extend the latter findings by
identifying a correlation between B. burgdorferi dissemin-
ation and the induction of a type I IFN response in mice.
Table 5 Culture of B. burgdorferi from tissues of mice infected with strains B515, B331 or B31-4
Number of samples with positive cultures/number tested (%)
Day 1 Day 14 Day 28
Skina Ear Ear Skina Bladder Joint
B31-4 0/4 (0) 0/9 (0) 0/9 (0) 0/9 (0) 0/9 (0) 0/9 (0)
B331 3/4 (75.0) 0/9 (0) 0/9 (0) 0/9 (0) 0/9 (0) 0/9 (0)
B515b 4/4 (100.0) 5/6 (83.3) 5/6 (83.3) 3/6 (50.0) 5/6 (83.3) 5/6 (83.3)
aSkin biopsy was collected from the inoculation site
bThree mice in the B515-infected group died of causes unrelated to the infection
Table 4 Transcripts significantly repressed in mouse blood in response to B. burgdorferi




Transcripts uniquely repressed by B. burgdorferi B515
Mm.1233 Fcer2a Fc receptor, IgE, low affinity II, alpha polypeptide Positive regulation of humoral Immune response
mediated by circulating immunoglobulin
−3.34 −1.42
Ighv14-2 immunoglobulin heavy variable 14-2 −2.59 −1.65
Mm.431426 Bach2 BTB and CNC homology 2 Regulation of transcription, DNA-dependent −2.42 −1.80
Mm.476307 Zfp799 zinc finger protein Regulation of transcription, DNA-dependent −2.40 −1.39
Mm.126193 Tnik TRAF2 and NCK interacting kinase Protein phosphorylation −2.39 −1.40
Mm.439662 Ebf1 early B cell factor Transcription, DNA-dependent −2.30 −1.28
Mm.486382 Gm8369 predicted gene 8369 −2.34 −1.90
Mm.482376 4833423F13 RIKEN cDNA 4833423F13 gene −2.33 −1.31
Rik
Mm.441077 BC002059 cDNA sequence BC002059 −2.33 −1.65
Mm.1850 Fcrla Fc receptor-like A Cell differentiation −2.21 −1.15
Mm.3411 Orc2 origin recognition complex, subunit 2 DNA replication −2.06 −1.73
Transcripts repressed by B. burgdorferi B515 and B331
Mm.271744 Pfn2 profilin 2 Cytoskeleton organization −3.14 −2.94
Mm.240047 Tnfrsf13c tumor necrosis factor receptor B-cell homeostasis −2.10 −2.16
superfamily, member 13c
Transcripts uniquely repressed by B. burgdorferi B331
Mm.41979 Mcpt8 mast cell protease 8 Proteolysis −1.52 −2.60
Mm.273270 Cbll1 Casitas B-lineage lymphoma-like 1 Negative regulation of cell adhesion −1.49 −2.30
aFC = fold change
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Factors other than spirochete density appear to be
critical for the induction of an IFN-responsive gene ex-
pression profile. Although viable spirochetes of B. burg-
dorferi strain B331 could be cultured from 24-h skin
biopsies, expression for many of the IFN-responsive
genes was significantly lower than that induced by an
equivalent inoculum of B. burgdorferi B515 (Fig. 4).
This result indicates that the magnitude of IFN-
responsive gene expression is not only dependent on
the presence of live spirochetes, but may also be an
intrinsic genomic property of the B. burgdorferi iso-
late. Since quantitative assessment of spirochete bur-
den by qPCR was not performed, no comparison can
be made of the relative numbers of spirochetes
present in the skin 24 h after infection. While this is
a limitation of the current study, the major goal was
to assess a correlation between expression of type I
IFN-related genes and the potential for dissemination,
which requires viable spirochetes; qPCR detects DNA
from both live and dead spirochetes [37]. Moreover,
several recent studies have found that spirochete
DNA present in infected mouse skin is close to the
limit of detection by qPCR prior to 72 or 96 h fol-
lowing inoculation, even when using DNA extracted
from a much larger quantity of skin than was col-
lected in this study [38, 39].
The results demonstrate that a B. burgdorferi strain
that causes disseminated infection induces the expres-
sion of IFN-responsive genes in the skin and blood of
infected animals. Previous studies had shown that
IFN-responsive gene expression is a crucial factor in
the development of Lyme arthritis in C3H mice [26].
The current findings indicate that these gene prod-
ucts might have additional roles during earlier stages
of infection. Interestingly, despite the induction of
IFN-responsive gene transcripts by B. burgdorferi
B515 in blood, transcripts for the interferons them-
selves were not detected by gene array analysis. This
could be due to the fact that dendritic cells, the clas-
sic type I IFN-producing cell type, account for a very
small percentage of the cellular components of blood
relative to the number of cells that are capable of ex-
pressing IFN-responsive genes. Alternatively, as the
presence of IFN transcripts in the blood was not
assessed by RT-PCR, the possibility that IFN tran-
script levels were below the threshold of detection by
gene array cannot be excluded. It should be noted
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Fig. 3 Expression profiling of type I IFN-related genes in B515-infected mouse skin. Skin biopsies were collected from the site of inoculation 24 h
after infection of mice with 1×104B. burgdorferi B515 spirochetes or with medium only (Control). Equivalent amounts of RNA from five animals per
experimental group were separately pooled and used as a template for RT-PCR using the RT2 Profiler PCR Array PAMM-016: Mouse Interferon α, β
Response kit. Gene symbols are used to designate transcripts that were found to be changed at least two-fold in B515-infected skin relative to
skin from controls. Fold change values are indicated in parentheses
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exposed to three different strains of B. burgdorferi
showed induction of the IFN-responsive gene tran-
scripts CXCL10, IRF1, STAT1, STAT2, OAS2, and
IFIH1, but no induction of any IFN [40]. In addition,
IFNs were not detectable by gene array analysis in the
ankle tissue of B. burgdorferi-infected mice which de-
veloped severe arthritis concomitant with the expres-
sion of numerous IFN-responsive genes [25].
In addition to IFN-related transcripts, the tran-
scripts that were most highly induced by B. burgdor-
feri B515 in mouse blood included a cluster of genes
with defined roles in antimicrobial defense, remodel-
ing of the extracellular matrix, dermal inflammatory
conditions, and dendritic cell functions, particularly in
skin (Table 3). Camp, an antimicrobial peptide with
multiple functions in innate immunity of the skin and
other epithelial barriers, is exploited by Staphylococ-
cus aureus to promote bacterial dissemination and
the establishment of invasive infection [41]. Formyl-
peptide receptor 2 (Fpr2), the receptor for Camp [42],
was also induced by B. burgdorferi B515 (Table 3).
Murine chitinase 3-like protein 3 (Chi3L3) is a
P<0.01
Mx1







































































































































































Fig. 4 IFN-related genes are induced at the site of inoculation in response to a disseminating B. burgdorferi strain. Groups of C3H/HeJ mice were
inoculated with 1x104 spirochetes of B. burgdorferi strains B515 (n = 9), B331 (n = 7) or B31-4 (n = 7), or with medium (control; n = 9). After 24 h skin
biopsies were collected from the site of inoculation and processed for RNA. Transcript levels for nine IFN-responsive genes were assessed for
individual animals by real-time RT-PCR. The mean fold change value for each experimental group was calculated relative to the mean value of
the control group and is indicated by a horizontal line. *, P < 0.05; **, P < 0.01; ***, P < 0.001 relative to the mean of the control group
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substrate for several matrix metalloproteases, includ-
ing MMP-9, and is upregulated in the EM skin lesions
of patients with acute Lyme disease [43]. Versican (Vcan)
mediates extracellular matrix remodeling by promoting
the interaction of pro-MMP-9 with gelatin and collagen
[44].
The observation that B. burgdorferi B515 induced the
expression of IFN-related genes in blood at 14 days
post-inoculation suggested that such a response might
occur at the initial infection site. Indeed, skin biopsies
collected 24 h after inoculation of mice with B. burgdor-
feri strain B515, but not with B. burgdorferi strains B331
or B31-4, showed induction of a number of IFN-
responsive genes. These same genes were among those
induced in human PBMCs that had been exposed ex
vivo to B. burgdorferi B515 [17, 23]. The presence of an
IFN-responsive gene profile in mouse skin biopsies leads
to the question of the identity of the inducing cytokine,
as many IFN-responsive genes can be induced by more
than one class of IFN. In the current study, transcript
levels for IFN-β were significantly induced, but tran-
scription of IFN-γ was not assessed. B. burgdorferi is a
potent inducer of IFN-γ, and both type I IFN and
IFN-γ are produced in the EM lesion blister fluids of
human Lyme disease patients [4]. In B. burgdorferi-
stimulated human PBMCs, transcript levels for IFN-γ
were observed to be at least 10-fold higher than
levels for either IFN-α or IFN-β [36]. While we can-
not exclude the possibility that the IFN-responsive
gene expression profile observed in 24-h skin biopsies
from mice infected with B. burgdorferi strain B515 is
elicited by contributions from both IFN-γ and IFN-β,
it should be noted that all strains, regardless of geno-
type, were equally effective at inducing high levels of
IFN-γ protein, while only strains of the RST1 genotype
elicited significantly higher production of IFN-α [23].
A limitation of the present study is that responses
to only three B. burgdorferi isolates were studied. B.
burgdorferi strain B515 is an RST1/OspC type A
genotype; numerous studies have revealed that strains
belonging to this genotype are genetically homoge-
neous, in contrast to RST2 and RST3 genotypes [45–
48]. Moreover, B. burgdorferi RST1 isolates have been
shown to induce significantly higher levels of IFN-α,
and possess a greater capacity to cause invasive infec-
tion, than do RST3 isolates [23, 24]. It is therefore
reasonable to predict that the findings of the present
study with regard to induction of IFN-responsive
genes in a genotype-specific manner would pertain to
other B. burgdorferi isolates.
In the present study, mice were infected by needle in-
oculation. This procedure allows for the standardization
of parameters, such as the number of spirochetes in the
inoculum and the time of inoculation, and has been
routinely employed to investigate the early kinetics of
B. burgdorferi infection [38, 39]. A limitation of this
approach is that it does not fully recapitulate physio-
logical infection by tick bite. Borrelia afzelii-induced
IFN signaling by mouse dendritic cells was suppressed
by Ixodes ricinus tick saliva in vitro, although the
amount of Ifnb transcript was not affected [49]. Tick
salivary gland extracts were found to have a cytotoxic
effect on human dermal fibroblasts in vitro [40], whereas
tick salivary gland lysates enhanced spirochete load in tis-
sues of infected mice [50]. In view of these findings, it
would be of interest in future studies to address the effects
of tick-related factors on the expression of IFN-responsive
genes in the skin by comparing the results of needle in-
oculation with those obtained following spirochete inocu-
lation via tick bite.
Induction of multiple IFN-responsive genes has been
observed in a range of skin pathologies, including auto-
immune skin inflammation [51], wound healing follow-
ing skin injury [52], and the development of adult and
juvenile dermatomyositis [53]. While predominantly host
protective during viral infections, type I IFNs have also
been shown to promote the pathogenesis of several
intracellular and extracellular bacteria, including species
that invade epithelial barriers [54–58]. One proposed
mechanism for type I IFN-mediated bacterial pathogen-
esis occurs via suppression of myeloid cells [59]. Indeed,
we have demonstrated that B. burgdorferi B31-A3, an
RST1 strain that readily disseminates in mice, induces
significantly higher expression of both IFN-α [23] and
indoleamine 2,3-dioxygenase [60], an enzyme with im-
munomodulatory functions in human myeloid and
plasmacytoid dendritic cells [61], as compared to a
mutant strain that is severely attenuated for infectivity.
Expression of indoleamine 2,3-dioxygenase was found to
be driven by the concerted actions of both B. burgdorferi-
induced IFN-γ and type I IFN [60]. The expression of
type I IFN and IFN-responsive genes in mouse skin
may therefore comprise a fingerprint of activated sup-
pressor dendritic cells, which potentially could be
manipulated by the spirochete in order to promote
pathogenesis.
Conclusions
Host transcriptional profiling was utilized to identify
transcriptional alterations in blood and skin during
B. burgdorferi infection in a murine infection model.
The results suggest a number of potential host-
protective and pathogen-promoting strategies that in-
clude the expression of antimicrobial peptides and
molecules involved in extracellular matrix remodel-
ing. Most notably, a strong association between early
expression of Ifnb and IFN-responsive genes at the site of
inoculation, and the capacity of certain B. burgdorferi
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strains to invade the bloodstream was observed. The
findings imply that type I IFNs may play a pivotal
role in the early stages of Lyme disease pathogenesis
and suggests a potential immune evasion strategy that
may be exploited by certain B. burgdorferi strains to
facilitate dissemination.
Methods
B. burgdorferi strains and clinical isolates
B. burgdorferi isolates B515 (RST1) and B331 (RST3A)
were obtained from skin biopsies taken from the EM
skin lesions of Lyme disease patients enrolled in a prior
study at the Lyme Disease Diagnostic Center at New
York Medical College, Valhalla, NY and have been previ-
ously described [13]. B. burgdorferi strain B31-4, a high
passage derivative of B. burgdorferi strain B31 (RST1)
that lacks all linear plasmids and consequently is unable
to disseminate in mice or induce IFN-α by human per-
ipheral blood mononuclear cells, has been previously
described [23, 34].
B. burgdorferi strains were grown at 37°C in modi-
fied Barbour-Stoenner-Kelly (BSK-S) medium [62].
Cultures were maintained at 37°C until spirochetes
reached the mid- to late-log phase of growth (4×107
to 8×107/ml). In the experiment performed to assess
induction of IFN transcripts in skin, B. burgdorferi
cultures were initially grown as above. However, to
simulate the temperature changes that occur during
transmission from tick to mammal and that may en-
hance the expression of certain virulence factors [63,
64], spirochetes were subcultured and grown at 25 °C
to the mid-log phase of growth, then diluted to 1 ×
106 spirochetes/ml and grown at 37 °C until cultures
once again reached mid- to late-log phase of growth
[65]. Spirochetes were enumerated and assessed for
motility using dark-field microscopy [66].
Mouse infection
All animal experimentation was conducted in strict ac-
cordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes of Health. The protocols were approved by the
Institutional Animal Care and Use Committee of New
York Medical College.
C3H/HeJ mice were employed throughout, as this
strain is susceptible to the development of Lyme
arthritis and produces a type I IFN response to B. burg-
dorferi infection [12, 13, 26]. For assessment of the host
transcriptional response in whole blood, specific
pathogen-free 6-8-week-old male or female C3H/HeJ
mice were randomly divided into groups of 15. Anes-
thetized mice were needle inoculated by intradermal in-
jection on the shaven back with 1x104 spirochetes of
B515 or B331 in 0.1 ml BSK-S. Control animals were
inoculated with 0.1 mL BSK-S alone. Whole blood sam-
ples were collected from each mouse at day 0 and day
14. Ear samples were obtained at day 14, and blood,
ear, joint and urinary bladder tissues were collected fol-
lowing euthanization on day 28.
To assess infectivity, blood and tissue samples were
cultured and serology was performed. Three to five
drops of whole blood were added directly to 4 ml of
BSK-S medium. Tissue samples (~10-20 mg) were
placed in 70 % ethanol for 3 min and transferred to
4.5 mL of BSK-S containing fosfomycin (20 μg/mL),
rifampicin (50 μg/mL), and amphotericin (2.5 μg/mL)
(Sigma-Aldrich, all) to inhibit the growth of commensal
bacteria [67]. Cultures were maintained at 37 °C for 4
weeks and examined weekly for the presence of spiro-
chetes. Serum collected at days 14 and 28 was probed for
the presence of anti-Borrelia antibodies using strain-
specific whole-cell lysates [68]. Tibiotarsal joints were
measured on days 7, 14, 21 and 28 using a digital metric
caliper through the thickest anteroposterior diameter of
the ankle.
In order to assess the type I IFN response in mouse
skin during early infection, groups of nine C3H/HeJ
mice were needle inoculated as described above with
1x104 spirochetes of B. burgdorferi strains B515 or
B331. As a control, a group of mice was infected with
1x104 spirochetes of B. burgdorferi strain B31-4. This
mutant derivative of B. burgdorferi strain B31 (RST1,
OspC A) lacks all linear plasmids, is unable to dis-
seminate in mice [34], and is unable to elicit IFN-α
secretion by human immune cells [23]. Skin biopsies
(~2 mm diameter) were collected from the injection
site 24 h after inoculation. The skin biopsy was cut
in half; one half was snap frozen and stored at −80 °
C for RNA isolation and the other half was washed
with 70 % ethanol, transferred to 5 mL of BSK-S con-
taining the antibiotics described above and incubated.
To assess spirochetal dissemination, ear, joint, and
urinary bladder tissues, and skin collected from the
site of inoculation, were collected following euthani-
zation at day 28 and assessed for the growth of spiro-
chetes as described above.
RNA isolation from murine skin biopsies
For real time RT-PCR analysis of individual IFN-
responsive genes, skin samples were homogenized in a
glass tissue homogenizer containing 300 μL of denatur-
ation solution from the Ambion ToTALLY RNA isolation
kit (Life Technologies, Grand Island, NY). Mouse hair was
removed from the samples by centrifugation at 3000 rpm
for 3 min and RNA was isolated from skin homogenates
using the Ambion ToTALLY RNA kit (Life Technologies).
Contaminating genomic DNA was removed by on-
column DNase I treatment using the Qiagen RNeasy Mini
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Kit (Qiagen, Valencia, CA). Total RNA was eluted in 30
μL of RNase/DNase-free water and quantitated by spec-
trophotometry (BioPhotometer, Eppendorf, Hauppauge,
NY). RNA samples were stored at −80°C after the addition
of 0.8 μL (32 U) of RNasin (Promega, Madison, WI).
Microarray hybridization and data analysis
Whole blood was collected from mice at 14 days post-
inoculation. In order to ensure a sufficient RNA yield,
samples from subgroups of three mice were pooled,
resulting in five biological replicates per experimental
group. RNA was isolated from whole blood using the
Gentra Purescript Blood RNA Isolation kit (Qiagen) and
stored at −80°C in the presence of RNase inhibitors until
processing. RNA quality was assessed using a bioana-
lyzer (Agilent Technologies, Santa Clara, CA) and by
spectrophotometric analysis. cDNA was generated by
amplification of the RNA using the Ovation RNA
Amplification System V2 (NuGEN Technologies, Inc.,
San Carlos, CA). cDNA was fragmented to 50–100
bp, labelled with biotin, and hybridized to the Mouse
430_2 GeneChip high-density oligonucleotide array
containing 39,000 mouse probe sets representing 34,000
genes (Affymetrix, Santa Clara, CA). Hybridization,
staining and washing of all arrays was performed in
an Affymetrix fluidics module. The dataset supporting
the results of this article is available in the ArrayExpress
database, accession number E-MTAB-3325 (http://
www.ebi.ac.uk/arrayexpress).
Microarray data were analyzed using GeneSpring
GX12.0 software (Agilent Technologies). Raw expression
values were normalized by robust multi-array averaging,
filtered to include only those probe sets with intensity
values above the 20th percentile, and baseline transformed
to the median of the control samples. Statistical signifi-
cance was determined by use of a one-way ANOVA with
Welch correction for unequal variances. Criteria for differ-
entially expressed transcripts included a P-value of <0.05
and at least a two-fold change relative to the control
group. Differentially expressed genes were subjected to
hierarchical clustering based on both transcripts and ex-
perimental condition.
PCR array
Total RNA was isolated from skin biopsies collected
from the site of inoculation in B. burgdorferi B515-
infected and medium-inoculated control mice, as de-
scribed above. For each experimental group, RNA from
five animals was pooled, and a total of 1 μg pooled RNA
was used as a template for first-strand cDNA synthesis.
IFN-associated gene transcription was measured using
the SABiosciences RT2 Profiler PCR Array PAMM-016:
Mouse Interferon α,β Response kit (Qiagen), according
to the manufacturer’s instructions.
Real-time quantitative RT-PCR
Real-time quantitative RT-PCR was used to validate
blood gene array data and to measure transcription of
type I IFN-responsive genes in mouse skin biopsies.
cDNA was synthesized from 1 μg of total RNA in 20-μl
reaction mixtures containing 250 μM of each dNTP,
0.5 μg random primers, 5 U AMV Reverse Transcriptase
(RT) enzyme, 10 U RNase inhibitor and 4 μL of 5X RT
buffer (all from Promega). Reactions were performed at
42 °C for 75 min and terminated by heating at 94 °C for
5 min. cDNA was stored at −20°C until use.
PCR was performed using the following TaqMan
Assays-on-Demand (Applied Biosystems, Grand Island,
NY): Camp (cathelicidin antimicrobial peptide;
Mm00438285_m1), Ccr7 (chemokine (C-C motif) recep-
tor 7; Mm01301785_m1), Cxcl10 (chemokine (C-X-C
motif) ligand 10; Mm00445235_m1), Gbp1 (guanylate
binding protein 1; Mm00657086_m1), Ifit1 (interferon-
induced protein with tetratricopeptide repeats 1;
Mm00515153_m1), Ifit3 (interferon-induced protein
with tetratricopeptide repeats 3; Mm01704846_s1),
Ifnb1 (interferon-beta; Mm00439552_s1), Irf3 (interferon
regulatory factor 3; Mm00516779_m1), Irf7 (interferon
regulatory factor 7; Mm00516788_m1), Mx1 (myxovirus
(influenza virus) resistance 1; Mm00487796_m1), Ngp
(neutrophil granule protein; Mm00476389_m1), Stat2
(signal transducer and activator of transcription 2;
Mm00490880_m1), and Vcan (Cspg2) (versican; chondro-
itin sulfate proteoglycan 2; Mm00490179_m1). All assays
were performed in duplicate in 25 μL reaction mixtures
containing TaqMan gene expression assay mix, FastStart
universal probe master mix (Roche), and 2 μL cDNA
(diluted 1:2) using the ABI 7900HT SDS sequence de-
tection system (Applied Biosystems), according to the
manufacturer’s instructions. As an internal control,
the expression of murine β-actin was measured in
duplicate for each sample using the TaqMan mouse
endogenous control assay (Actb; Mm00607939_s1,
Applied Biosystems). The ΔΔCt relative quantitation
method was used to calculate differential gene expres-
sion between groups [69].
Statistical analysis
Statistical significance of differences between the mean
RT-PCR fold-change values of experimental groups was
determined using a one-way ANOVA with Tukey-
Kramer’s post-hoc test (GraphPad Prism, version 5.03;
GraphPad Software, San Diego, CA). A Fisher’s exact
test was performed to determine significant differences
in the numbers of infected tissues.
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